BIOMAT Database Logo BIOMAT Database Logo

HIV-1 drug resistance in antiretroviral-naive patients in sub-Saharan Africa. 2012

Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D024882 Drug Resistance, Viral The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation. Antiviral Drug Resistance,Antiviral Drug Resistances,Drug Resistances, Viral

Related Publications

Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
HIV-1 drug resistance in antiretroviral-naive patients in sub-Saharan Africa.
March 2013, The Lancet. Infectious diseases,
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
November 2011, AIDS (London, England),
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
October 2011, The Lancet. Infectious diseases,
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa.
January 2013, Current opinion in HIV and AIDS,
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
Pretreatment HIV-1 drug resistance testing in sub-Saharan Africa.
December 2012, The Lancet. Infectious diseases,
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
January 2008, Antiviral therapy,
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
November 2016, The Lancet. Infectious diseases,
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa.
June 2018, AIDS (London, England),
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
Antiretroviral drug resistance in HIV-1 therapy-naive patients in Cuba.
June 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases,
Anthony Amoroso, and Martine Etienne-Mesubi, and Anthony Edozien, and Olurotimi O Mesubi, and Thomasine Guberski
Antiretroviral drug resistance--implications for HIV/AIDS reduction in sub-Saharan Africa and other developing countries.
January 2010, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria,
Copied contents to your clipboard!